EverSource Wealth Advisors’s LYRA THERAPEUTICS INC LYRA Stock Holding History

EverSource Wealth Advisors’s Portfolio LYRA Stock Details LYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-338	Closed	-$1.04K	–	4460
2025 Q4	$1.04K	Sell	338 -7	-2%	-$35	﹤0.01%	3699
2025 Q3	$2.25K	Sell	345 -13	-4%	-$95	﹤0.01%	3479
2025 Q2	$3.21K	Buy	358 +351	+5,014%	+$2.91K	﹤0.01%	3331
2025 Q1	$43	Buy	7 +5	+250%	+$47	﹤0.01%	3909
2024 Q4	$25	Buy	+2	New	+$22	﹤0.01%	3696

Other funds holding LYRA

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

EverSource Wealth Advisors's LYRA Position: Q1 2026 in Review

EverSource Wealth Advisors sold out of LYRA THERAPEUTICS INC (LYRA) in Q1 2026, closing a stake of 338 shares — an estimated $1.04K sold.

EverSource Wealth Advisors first reported a position in LYRA in Q4 2024 and held it in 5 quarters. The position peaked at $3.21K in Q2 2025. 1 fund tracked by Wall St. Rank holds LYRA as of Q1 2026.

EverSource Wealth Advisors reported no remaining LYRA THERAPEUTICS INC position as of Q1 2026 after selling out during the quarter.
EverSource Wealth Advisors sold 338 LYRA THERAPEUTICS INC shares in Q1 2026, an estimated $1.04K.
EverSource Wealth Advisors first reported a position in LYRA THERAPEUTICS INC in Q4 2024 and held it in 5 quarters.
EverSource Wealth Advisors's LYRA THERAPEUTICS INC position peaked at $3.21K in Q2 2025.
1 fund tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.